These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

191 related items for PubMed ID: 17454859

  • 21. Treatment of large hepatocellular carcinoma: comparison between techniques and long term results.
    Ferrari FS, Stella A, Gambacorta D, Magnolfi F, Fantozzi F, Pasquinucci P, Civeli L, Pieraccini M.
    Radiol Med; 2004 Oct; 108(4):356-71. PubMed ID: 15525889
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. [Studies on combination therapy with TAE and percutaneous ethanol injection therapy for unresectable hepatocellular carcinoma].
    Tateishi H, Hasuike Y, Kinuta M, Furukawa J, Takata N, Maruyama H, Oi H, Yayoi E, Okamura J.
    Gan To Kagaku Ryoho; 1993 Aug; 20(11):1492-4. PubMed ID: 8396903
    [Abstract] [Full Text] [Related]

  • 27. Acute renal failure after transarterial chemoembolization for hepatocellular carcinoma: a retrospective study of the incidence, risk factors, clinical course and long-term outcome.
    Huo TI, Wu JC, Huang YH, Chiang JH, Lee PC, Chang FY, Lee SD.
    Aliment Pharmacol Ther; 2004 May 01; 19(9):999-1007. PubMed ID: 15113367
    [Abstract] [Full Text] [Related]

  • 28. Standards for selecting percutaneous ethanol injection therapy or percutaneous microwave coagulation therapy for solitary small hepatocellular carcinoma: consideration of local recurrence.
    Horigome H, Nomura T, Saso K, Itoh M.
    Am J Gastroenterol; 1999 Jul 01; 94(7):1914-7. PubMed ID: 10406259
    [Abstract] [Full Text] [Related]

  • 29. Transarterial injection of (131)I-lipiodol, compared with chemoembolization, in the treatment of unresectable hepatocellular cancer.
    Marelli L, Shusang V, Buscombe JR, Cholongitas E, Stigliano R, Davies N, Tibballs J, Patch D, Meyer T, Burroughs AK.
    J Nucl Med; 2009 Jun 01; 50(6):871-7. PubMed ID: 19443599
    [Abstract] [Full Text] [Related]

  • 30. Predicting survival in patients with hepatocellular carcinoma treated by transarterial chemoembolisation.
    Cabibbo G, Genco C, Di Marco V, Barbara M, Enea M, Parisi P, Brancatelli G, Romano P, Craxì A, Cammà C.
    Aliment Pharmacol Ther; 2011 Jul 01; 34(2):196-204. PubMed ID: 21564144
    [Abstract] [Full Text] [Related]

  • 31. Reappraisal of repeated transarterial chemoembolization in the treatment of hepatocellular carcinoma with portal vein invasion.
    Kim KM, Kim JH, Park IS, Ko GY, Yoon HK, Sung KB, Lim YS, Lee HC, Chung YH, Lee YS, Suh DJ.
    J Gastroenterol Hepatol; 2009 May 01; 24(5):806-14. PubMed ID: 19207681
    [Abstract] [Full Text] [Related]

  • 32. [Advanced hepatocellular carcinoma: therapeutic results in 110 patients and therapeutic strategy].
    Inoue Y, Ishida T, Murakami T, Nakamura H.
    Gan To Kagaku Ryoho; 1998 Oct 01; 25(12):1857-64. PubMed ID: 9797808
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Liver resection or combined chemoembolization and radiofrequency ablation improve survival in patients with hepatocellular carcinoma.
    Helmberger T, Dogan S, Straub G, Schrader A, Jüngst C, Reiser M, Waggershauser T, Jakobs T, Hoffmann RT, Löhe F, Graeb C, Rau HG, Schauer R, Jauch KW, Caselmann WH, Göke B, Jüngst D.
    Digestion; 2007 Oct 01; 75(2-3):104-12. PubMed ID: 17598962
    [Abstract] [Full Text] [Related]

  • 37. Combination therapy with transarterial chemoembolization and interferon-alpha compared with transarterial chemoembolization alone for hepatitis B virus related unresectable hepatocellular carcinoma.
    Li M, Lu C, Cheng J, Zhang J, Cao C, Xu J, Xu J, Pan H, Zhong B, Tucker S, Wang D.
    J Gastroenterol Hepatol; 2009 Aug 01; 24(8):1437-44. PubMed ID: 19486255
    [Abstract] [Full Text] [Related]

  • 38. Prognostic values of alpha-fetoprotein and protein induced by vitamin K absence or antagonist-II in hepatitis B virus-related hepatocellular carcinoma: a prospective study.
    Kim HS, Park JW, Jang JS, Kim HJ, Shin WG, Kim KH, Lee JH, Kim HY, Jang MK.
    J Clin Gastroenterol; 2009 Aug 01; 43(5):482-8. PubMed ID: 19197197
    [Abstract] [Full Text] [Related]

  • 39. Preoperative combined with postoperative chemoembolization can improve survival in patients with hepatocellular carcinoma: a single-center study.
    Liu Y, Yang R.
    J Vasc Interv Radiol; 2009 Apr 01; 20(4):472-83. PubMed ID: 19250841
    [Abstract] [Full Text] [Related]

  • 40. Response to preoperative chemoembolization correlates with outcome after liver transplantation in patients with hepatocellular carcinoma.
    Millonig G, Graziadei IW, Freund MC, Jaschke W, Stadlmann S, Ladurner R, Margreiter R, Vogel W.
    Liver Transpl; 2007 Feb 01; 13(2):272-9. PubMed ID: 17256758
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.